Amphastar exec Zhou sells 10,000 shares at $23.94
Amphastar’s Senior EVP exercised 10,000 options and sold 10,000 common shares on September 16, 2026, in a net-sell Form 4 transaction.
Rhea-AI Filing Summary
Amphastar Pharmaceuticals, Inc. (AMPH) officer Rong Zhou, Senior EVP, Production Center, exercised options for 10,000 shares of common stock on September 16, 2026 at an exercise price of $13.35 per share and sold 10,000 shares the same day at a weighted average price of $23.94. Following the option exercise, Zhou held 19,424 stock options directly, and also has indirect ownership interests in common shares held by the Zhou Family Trust and by the reporting person’s spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F4 | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $13.35 | $134K |
| Sale | Common Stock F1 | 10,000 | $23.9404 | $239K |
| holding | Common Stock F2 | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
Footnotes (4)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.83 to $24.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F2. The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.
- F3. The shares are held of record by the reporting person's spouse.
- F4. Shares subject to the option are fully vested and immediately exercisable.
Key Figures
Key Terms
Employee Stock Option (right to buy) financial
weighted average price financial
indirect financial
fully vested and immediately exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amphastar (AMPH) executive Rong Zhou report on this Form 4?
What was the option exercise price reported by Amphastar (AMPH) executive Rong Zhou?
How many Amphastar (AMPH) options does Rong Zhou hold after the reported transactions?
Were the Amphastar (AMPH) transactions under a Rule 10b5-1 trading plan?
What indirect Amphastar (AMPH) holdings are disclosed for Rong Zhou?
AI-generated analysis. How Rhea-AI works. Not financial advice.